Dr Reddy’s Lab trades up on the bourses

Dr Reddys Laboratories is currently trading at Rs. 2559.00, up by 3.00 points or 0.12% from its previous closing of Rs. 2556.00 on the BSE. The scrip opened at Rs. 2552.20 and has touched a high and low of Rs. 2577.00 and Rs. 2552.20 respectively. So far 6334 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 2939.80 on 28-Feb-2014 and a 52 week low of Rs. 1860.00 on 22-Apr-2013. Last one week high and low of the scrip stood at Rs. 2608.10 and Rs. 2522.00 respectively. The current market cap of the company is Rs. 43479.83 crore. The promoters holding in the company stood at 25.52% while Institutions and Non-Institutions held 40.59% and 15.87% respectively. Foreign Institutional Investors (FIIs) have raised their stake in Dr Reddy’s Laboratories, an integrated global pharmaceutical company to 34.30% at the end of March 2014 quarter from 33.35% as on December 31, 2013. On the other hand, domestic institutional investors’ (DIIs) shareholding has decreased to 6.29% at the end of March 2014 quarter from 7.54% as on December 31, 2013. Under DIIs, mutual funds / UTI held maximum stake of 4.89%, followed by insurance companies (1.34 % stake) and Financial Institutions / Banks (0.06 stake). Meanwhile, promoter and promoter group shareholding was unchanged at 25.52% at the end of March 2014 quarter. Dr. Reddy’s is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs.